Home
Live Updates
Exact Sciences (EXAS) Q3 2023 Earnings Call Transcript : vimarsana.com
Exact Sciences (EXAS) Q3 2023 Earnings Call Transcript
EXAS earnings call for the period ending September 30, 2023.
Related Keywords
Japan ,
Seattle ,
Washington ,
United States ,
Wisconsin ,
Japanese ,
Americans ,
William Blair ,
America Merrill Lynch ,
Andrew Brackmann William Blair ,
Kevin Conroy ,
Dan Brennan ,
Mark Massaro ,
Megan Jones ,
Puneet Souda Leerink ,
Patrick Donnelly Citi ,
Vijay Kumar Evercore ,
Goldman Sachs ,
Matt Sykes Goldman Sachs ,
Erik Holznecht ,
Jeff Elliott ,
Dan Leonard ,
Brandon Couillard Jefferies ,
Everett Cunningham ,
Kyle Mikson Canaccord Genuity ,
European Society Of Medical Oncology Congress ,
Jack Meehan Nephron Research Analyst ,
Derik De Bruin Bank ,
Health Systems ,
Company Analyst ,
Jack Meehan At Nephron Research ,
United States Preventive Services Task ,
Dan Arias Stifel Financial Corp ,
Albert Hu Craig Hallum Capital Group Analyst ,
American College Of Gastroenterology Conference ,
Exact Sciences ,
Exact Science ,
Motley Fool Stock Advisor ,
Stock Advisor ,
Chief Executive ,
Resolution Biosciences ,
American College ,
Gastroenterology Conference ,
Precision Oncology ,
European Society ,
Medical Oncology ,
Financial Officer ,
Chief Operating ,
Catherine Schulte ,
Brandon Couillard ,
New Year ,
Derek De Bruin ,
Andrew Brackmann ,
Vijay Kumar ,
Res Bio ,
Matt Sykes ,
Patrick Donnelly ,
Jack Meehan ,
United States Preventive Services Task Force ,
Puneet Souda ,
Cologuard Blood ,
Dan Arias ,
Analyst Day ,
Kyle Mikson ,
Eve Burstein ,
Scare Gap ,
Alex Nowak ,
Hallum Capital Group ,
Chief Commercial ,
Nephron Research ,
Leerink Partners ,
Stifel Financial ,
vimarsana.com © 2020. All Rights Reserved.